MAKO Surgical Corp (MAKO) Posts Q3 Loss of $0.24

MAKO Surgical Corp (NASDAQ: MAKO) reported Q3 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $20 million versus the consensus estimate of $19.4 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c